Vaccination against a single strain of Zika virus should be sufficient to protect against genetically diverse strains of the virus, according to a study conducted by investigators from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH); Washington University in St. Louis; and Emory University in Atlanta.
KA Dowd et al. Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype. Cell Reports DOI: 10.1016/j.celrep.2016.07.049 (2016).
NIAID Director Anthony S. Fauci, M.D., and Theodore C. Pierson, Ph.D., chief, Viral Pathogenesis Section of NIAID’s Laboratory of Viral Diseases and a co-author on the paper, are available for comment.